Larry Wonshin Kwak MD

Deputy Director, Comprehensive Cancer Center Director, Toni Stephenson Lymphoma Center City of Hope

1500 Duarte RdDuarte, CA 91010
Phone+1 626-256-4673

Dr. Kwak is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kwak's full profile Already have an account?

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1987 - 1991
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1984 - 1987
Northwestern University The Feinberg School of MedicineClass of 1982

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2015 - 2027
TX State Medical License 2005 - 2024
MD State Medical License 1991 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Sunrise Ambulatory Care, Allscripts, 2013-2017
CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2017
CMS Meaningful Use Stage 2 Certification Allscripts FollowMyHealth, Allscripts, 2013-2017

Clinical Trials

Vaccine Therapy in Treating Patients With Multiple Myeloma
COMPLETED
PHASE2

Publications & Presentations

PubMed

Harnessing neoantigen-specific T cells for precision immunotherapy in hematologic malignancies.
Anmol Kandel, Soung-Chul Cha, Larry W Kwak
Blood. 2026-08-06
B-cell activating factor receptor expression in B-lymphoblastic leukaemia: Flow cytometric analysis and implications for targeted therapy.
Parastou Tizro, Ibrahim Aldoss, Xiuli Wang, Larry W Kwak, Zhenyuan Dong
British Journal of Haematology. 2026-07-24
CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.
V Rakesh Sethapati, Vu Ngo, Alexey Danilov, Tycel Phillips, Geoffrey Shouse
American Journal of Clinical Pathology. 2026-06-04

Journal Articles

Long‐Term Overall‐ and Progression‐Free Survival After Pentostatin, Cyclophosphamide and Rituximab Therapy for Indolent Non‐Hodgkin Lymphoma
Peter McLaughlin, M Alma Rodriguez, Sattva S Neelapu, Anas Younes, Lei Feng, Michelle A Fanale, Felipe Samaniego, Barbara Pro, Luis Fayad, Fredrick Hagemeister, Jorge ..., British Journal of Haematology
Phase I Study of an Active Immunotherapy for Asymptomatic Phase Lymphoplasmacytic Lymphoma with DNA Vaccines Encoding Antigen-Chemokine Fusion: Study Protocol
Sattva S Neelapu, D Lynne Smith, Vincent Y Lee, Larry W Kwak, Sheeba K Thomas, BioMed Central

Abstracts/Posters

Preliminary Results from a Phase 2 Trial of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed By BV Consolidation in...
Larry W Kwak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Overcoming CD19 Antigen Loss in B-Cell Malignancies with CAR T Cells Targeting BAFF-R
Larry W Kwak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Preliminary Results from a Phase I Trial of Pembrolizumab Plus Vorinostat in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, a...
Larry W Kwak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Caught in the Crossfire: The Critical Threats Facing Cancer Centers, Research, and Patient CareMarch 21st, 2025
New Cancer Vaccines on the Horizon: Renewed Hope or Hype?December 6th, 2024
City of Hope Vaccine Experts Report Positive Results on Phase 1 Trial of Personalized Vaccine for Lymphoplasmacytic LymphomaSeptember 19th, 2024

Grant Support

BAFF-R CAR T cell therapy for ALLBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2022–2027
City of Hope Lymphoma SPOREBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2004–2025
P1 - Combination Activated T-Cell And Vaccine Therapy In MyelomaNational Cancer Institute2010–2011
Career Development ProgramNational Cancer Institute2010–2011
Immunization Of Stem Cell Transplant Donors To Enhance Graft-Versus-Tumor EffectNational Cancer Institute2007–2008